Atlas Trials

Role of ERBT Plus Intravesical BCG in Intermediate-Risk or High-Risk NMBC

Clinical trial NCT07724886 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07724886
Sponsor
Chinese University of Hong Kong
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Bladder Cancer
Start date
2026-07-01
Primary completion
2029-12-31
Enrollment
732

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.